Diabetes Mellitus, Type 2 — SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation.
Citation(s)
SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation: A Randomised Double-blind Placebo-controlled Trial (The SEESAW Study)